Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

奥美沙坦酯氢氯噻嗪片 - NMPA Drug Approval Details

Approvals/NMPA/Olmesartan Medoxomil and Hydrochlorothiazide Tablets

Approved

化学药品

Olmesartan Medoxomil and Hydrochlorothiazide Tablets

宁波科尔康美诺华药业有限公司🇨🇳 National Medical Products Administration

Approval Date: Dec 1, 2024
Approval ID: 8fOLlvVzSYx
Company: 宁波科尔康美诺华药业有限公司
Type: 化学药品

Approval Details

Approval Id: 8fOLlvVzSYx
Approval Number: 国药准字H20249578
Generic Name: 奥美沙坦酯氢氯噻嗪片
Generic Name En: Olmesartan Medoxomil and Hydrochlorothiazide Tablets
Drug Type: 化学药品
Dosage Form: 片剂
Strength: 每片含奥美沙坦酯20mg与氢氯噻嗪12.5mg
Reg Date: 2024-12-01
Company Name: 宁波科尔康美诺华药业有限公司
Company Address: 浙江省宁波高新区扬帆路999弄1号楼<14-2>
Production Company Name: 宁波美诺华天康药业有限公司
Production Company Address: 浙江省宁波市北仑区大榭街道滨海西路85号
Company Detail Path: /organization/909939d9b8da3458/zhu-bo-ke-er-kang-mei-nuo-hua-yao-ye-you-xian-gong-si
Production Company Detail Path: /organization/15be53a01261d4de/zhu-bo-mei-nuo-hua-tian-kang-yao-ye-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Dec 1, 2024

Approval ID

8fOLlvVzSYx

Type

化学药品

Back to NMPA Approvals